Compare ATCH & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATCH | MODD |
|---|---|---|
| Founded | 2022 | 1998 |
| Country | United States | United States |
| Employees | 43 | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 33.3M |
| IPO Year | N/A | N/A |
| Metric | ATCH | MODD |
|---|---|---|
| Price | $0.24 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 171.3K |
| Earning Date | 02-13-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $14,613,715.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.72 | ★ N/A |
| Revenue Growth | ★ 52.99 | N/A |
| 52 Week Low | $0.14 | $0.28 |
| 52 Week High | $13.19 | $1.29 |
| Indicator | ATCH | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 52.53 |
| Support Level | $0.23 | $0.42 |
| Resistance Level | $0.28 | $0.49 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 28.52 | 48.41 |
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.